Home / 510(k) Clearances / K251580

510(k) K251580

MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD) by Liofilchem S. R. L. — Product Code JWY

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 20, 2025
Date Received
May 23, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Manual Antimicrobial Susceptibility Test Systems
Device Class
Class II
Regulation Number
866.1640
Review Panel
MI
Submission Type

Other clearances by Liofilchem S. R. L.

  • K252114 — MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL (October 2, 2025)
  • K243202 — MTS Ceftobiprole 0.002-32 µg/mL (January 30, 2025)
  • K230479 — ComASP Cefiderocol 0.008-128 (May 18, 2023)
  • K211672 — MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL (October 20, 2021)
  • K200180 — MTS Omadacycline 0.002 - 32 ug/mL (March 20, 2020)
  • K192345 — MTS Ampicillin-Sulbactam 0.016/0.008 - 256/128 µg/mL (October 31, 2019)
  • K191908 — MTS Imipenem 0.016-256 µg/mL (September 4, 2019)
  • K191809 — MTS Imipenem-relebactam 0.002/4-32/4 µg/mL (August 23, 2019)
  • K190914 — MTS Doxycycline 0.016 - 256 µg/mL (May 29, 2019)
  • K190252 — MTS Gentamicin 0.016 - 256 µg/mL (March 22, 2019)

Other clearances for product code JWY

  • K252114 — MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL (October 2, 2025)
  • K252062 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin (September 25, 2025)
  • K250575 — The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreon (September 5, 2025)
  • K252014 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin (August 28, 2025)
  • K250990 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciproflox (June 30, 2025)
  • K242843 — The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) M (June 20, 2025)
  • K250856 — ETEST Aztreonam/Avibactam (AZA) (0.016/4-256/4 µg/mL) (June 12, 2025)
  • K242659 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomyci (May 22, 2025)
  • K250274 — ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) (April 30, 2025)
  • K242658 — The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxa (April 15, 2025)